首页> 外文期刊>Bipolar disorders. >Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non‐psychotic mania and non‐psychotic bipolar depression
【24h】

Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non‐psychotic mania and non‐psychotic bipolar depression

机译:与非精神病躁狂症和非精神病双相抑郁症相比,精神病躁狂症和精神病双相抑郁症的精神疗法治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives An evidence base for the treatment of mania and bipolar depression with psychotic symptoms is lacking. Nevertheless, clinicians may have a preference for treating episodes of bipolar disorder with or without psychotic symptoms in different ways, which is likely to reflect notions of differential efficacy of treatments between these subtypes. This study aimed to investigate whether the psychopharmacological treatment of psychotic and non‐psychotic episodes of mania and bipolar depression, respectively, differs in clinical practice. Methods We conducted a register‐based study assessing the psychopharmacological treatment of all individuals receiving their first diagnosis of mania or bipolar depression between 2010 and 2012. The psychopharmacological treatment within 3?months following the time of diagnosis was considered. Potential differences in psychopharmacological treatment between the psychotic and non‐psychotic subtypes of mania and bipolar depression, respectively, were investigated by means of Pearson's χ 2 test and logistic regression adjusted for sex and age at diagnosis of bipolar disorder. Results A total of 827 patients were included in the analyses. The adjusted odds ratio ( aOR ) for treatment with an antipsychotic was 1.71 (95% confidence interval [CI] : 1.18‐2.48, P .01) for psychotic mania and 3.89 (95% CI: 1.95‐7.76, P .001) for psychotic bipolar depression. The aOR for treatment with the combination of an antipsychotic and an anticonvulsant was 1.60 (95% CI: 1.06‐2.43, P .05) for psychotic mania. The aOR for treatment with the combination of an antipsychotic and an antidepressant was 2.50 (95% CI: 1.43‐4.37, P .01) for bipolar psychotic depression. Conclusions It would be of interest to conduct studies evaluating whether antipsychotics represent the superior pharmacological treatment for psychotic mania and psychotic bipolar depression.
机译:目的缺乏精神病症状治疗躁狂症和双相抑郁症的证据基础。然而,临床医生可能偏好以不同方式与精神病症状治疗双相情感障碍的发作,这可能反映了这些亚型之间治疗的差异疗效的概念。本研究旨在调查疾病和双相抑郁症的精神病和非精神病发作的精神武装治疗是否与临床实践不同。方法采用基于寄存器的研究,评估了2010年至2012年间接受其第一次诊断躁狂症或双相抑郁症的所有个人的精神医学疗法。在诊断时3个月内的精神医学治疗。通过Pearson的χ2检验和逻辑回归分别调查了躁狂症和双相抑郁症的精神病和非精神病患者的精神医学治疗潜在差异,调整了双相障碍的性和年龄的性别和年龄。结果共分析共有827名患者。用抗精神病药物治疗的调整后的差距(AOR)为1.71(95%置信区间[CI]:1.18-2.48,P <.01),适用于精神病躁狂症和3.89(95%CI:1.95-7.76,P& .001)用于精神病双极抑郁症。用于用抗精神病药和抗惊厥药的组合治疗的AOR为1.60(95%CI:1.06-2.43,P&。05)。用于用抗精神病药物和抗抑郁药的组合治疗的AOR为双极精神病抑郁症的2.50(95%CI:1.43-4.37,P <.01)。结论进行研究评估抗精神病药是否代表精神病躁狂症和精神病双相抑郁症的优质药理学治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号